Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Amber Leis

Plastic Surgery Saint Louis, MO Medical Doctor

NPI 1649442328 CMS profile 1340601

1 Barnes Jewish Hospital Plz, Div Surg Plastics, Saint Louis, MO 63110

Open in the dashboard

General payments

$133,473

226 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Amber Leis of Saint Louis, MO is reported in the CMS Open Payments database as having received $133,473 across 226 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $18,319 32
2024 General $20,605 52
2023 General $45,676 49
2022 General $22,789 36
2021 General $5,780 27
2020 General $4,051 10
2019 General $16,254 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Amber Leis
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Amber Leis were reported at $18,319. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Amber Leis Plastic Surgery median Middle half National median
2019 $16,254 $371 $122–$1,483 $163
2020 $4,051 $158 $52–$438 $114
2021 $5,780 $249 $87–$752 $132
2022 $22,789 $274 $102–$793 $149
2023 $45,676 $299 $113–$891 $160
2024 $20,605 $361 $124–$1,062 $164
2025 $18,319 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AxoGen $103,192 94 payments
  2. Checkpoint Surgical, Inc $18,302 34 payments
  3. Biocircuit Technologies Inc $3,766 5 payments
  4. Sientra, Inc. $1,195 13 payments
  5. TELA Bio, Inc. $1,190 9 payments
  6. Mentor Worldwide LLC $851 8 payments
  7. AbbVie, Inc. $747 12 payments
  8. Allergan Inc. $665 9 payments
  9. Integra LifeSciences Corporation $530 8 payments
  10. TriMed, Inc. $457 4 payments
  11. Other $2,579 30 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $39,288 10 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $34,937 7 payments
  3. Consulting Fee $27,538 20 payments
  4. Food and Beverage $18,799 168 payments
  5. Travel and Lodging $12,792 20 payments
  6. Education $120 1 payment
Products named General payments · program years 2019–2025
  1. Avance Nerve Graft $77,709 71 payments
  2. AXOGUARD NERVE PROTECTOR $68,068 49 payments
  3. AxoGuard Nerve Connector $68,068 49 payments
  4. Checkpoint Stimulators $18,302 34 payments
  5. AXOGUARD HA+ NERVE PROTECTOR Neurology $10,506 6 payments
  6. AXOGUARD Neurology $10,506 6 payments
  7. AXOGUARD NERVE CAP Neurology $10,506 6 payments
  8. AXOGUARD Neurology $10,506 6 payments
  9. AXOGUARD NERVE CAP Neurology $7,251 10 payments
  10. Axoguard HA+ Nerve Protector Neurology $7,251 10 payments
  11. Other $12,506 121 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$20,211

Medicare's payments for the services billed

Medicare patients

41

Average age 67

Services billed

125

20 women, 21 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 66%
High blood pressure 63%
Ischemic heart disease 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

226 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record